EPIRUS Biopharmaceuticals, Inc. (EPRS) financial statements (2020 and earlier)

Company profile

Business Address 699 BOYLSTON ST
BOSTON, MA 02116
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

3/31/2016
Q1
12/31/2015
Q4
9/30/2015
Q3
6/30/2015
Q2
3/31/2015
Q1
12/31/2014
Q4
9/30/2014
Q3
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments21324458622124
Cash and cash equivalents21324458622124
Receivables  0    
Prepaid expense 1  01 
Assets held-for-sale, not part of disposal group  4  
Deferred tax assets  0    
Other current assets 1  00 
Other undisclosed current assets5221102
Total current assets:26355159632326
Noncurrent Assets
Property, plant and equipment3211111
Intangible assets, net (including goodwill)33333322222222
Goodwill26262816161616
Intangible assets, net (excluding goodwill)6656666
Restricted cash and investments0222222
Other noncurrent assets0000000
Other undisclosed noncurrent assets   3444
Total noncurrent assets:36373628282828
TOTAL ASSETS:61728787915154
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities77129687
Accounts payable4232322
Accrued liabilities3465345
Employee-related liabilities  21111
Interest and dividends payable  0000 
Settlement liabilities0111   
Debt151521   
Deferred revenue and credits310000 
Deferred tax liabilities0000000
Other liabilities0001110
Other undisclosed current liabilities7106(1)(1)(1)(1)
Total current liabilities:33332110677
Noncurrent Liabilities
Long-term debt and lease obligation  131477 
Long-term debt, excluding current maturities  131477 
Liabilities, other than long-term debt2222222
Deferred revenue and credits1111111
Deferred tax liabilities, net0000111
Other liabilities0000111
Other undisclosed noncurrent liabilities11     
Total noncurrent liabilities:3315161092
Total liabilities:3536362616179
Stockholders' equity
Stockholders' equity attributable to parent26365159743242
Common stock0000000
Additional paid in capital181175174168168119119
Accumulated other comprehensive income (loss)0(0)(0)    
Accumulated deficit(155)(139)(123)(109)(94)(87)(76)
Total stockholders' equity:26365159743242
Other undisclosed liabilities and equity  03222
TOTAL LIABILITIES AND EQUITY:61728787915154

Income statement (P&L) ($ in millions)

3/31/2016
Q1
12/31/2015
Q4
9/30/2015
Q3
6/30/2015
Q2
3/31/2015
Q1
12/31/2014
Q4
9/30/2014
Q3
Revenues100000 
Revenue, net10000  
Other undisclosed gross profit (0)     
Gross profit:10000  
Operating expenses(17)(16)(14)(15)(7)(10)(14)
Other undisclosed operating income     0 
Operating loss:(16)(16)(14)(15)(7)(10)(14)
Nonoperating income (expense)(0)1(0)(0)(0)(0)(0)
Other nonoperating income (expense)0 (0)(0)(0)(0)(0)
Other undisclosed income from continuing operations before equity method investments, income taxes     0 
Loss from continuing operations before equity method investments, income taxes:(16)(15)(14)(15)(8)(10)(14)
Other undisclosed loss from continuing operations before income taxes     (0) 
Loss from continuing operations before income taxes:(16)(15)(14)(15)(8)(10)(14)
Income tax benefit0000000
Net loss available to common stockholders, diluted:(16)(15)(14)(15)(8)(10)(14)

Comprehensive Income ($ in millions)

3/31/2016
Q1
12/31/2015
Q4
9/30/2015
Q3
6/30/2015
Q2
3/31/2015
Q1
12/31/2014
Q4
9/30/2014
Q3
Net loss:(16)(15)(14)(15)(8)(10)(14)
Other comprehensive loss(0)      
Comprehensive loss:(16)(15)(14)(15)(8)(10)(14)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent0(0)(0)    
Comprehensive loss, net of tax, attributable to parent:(16)(15)(14)(15)(8)(10)(14)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: